carbapenems has been researched along with baicalein in 2 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (baicalein) | Trials (baicalein) | Recent Studies (post-2010) (baicalein) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 1,322 | 9 | 839 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hu, L; Hu, P; Weng, Y | 1 |
Çakıral, K; Güran, M; Kandemir, T; Köksal, F; Nagiyev, T; Öcal, MM; Şanlıtürk, G; Teralı, K | 1 |
2 other study(ies) available for carbapenems and baicalein
Article | Year |
---|---|
Baicalein Inhibits Plasmid-Mediated Horizontal Transmission of the blaKPC Multidrug Resistance Gene from Klebsiella pneumoniae to Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Paraoxon; Plasmids | 2023 |
Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests | 2023 |